Literature DB >> 14983133

High-altitude-related disorders--Part II: prevention, special populations, and chronic medical conditions.

George W Rodway1, Leslie A Hoffman, Mark H Sanders.   

Abstract

This second section of a 2-part review on high-altitude-related disorders focuses on strategies for prevention of high-altitude illness, identification of populations at increased risk for high-altitude illness, and effects of high altitude on selected chronic medical conditions. Practical aspects of advising and educating patients traveling to high altitude will be discussed, with special reference to pregnant women, infants and young children, healthy elders, and chronic medical conditions that may place persons at greater risk for high-altitude illness. The special concerns of pre-verbal children will be covered relative to the risks of high altitude for those too young to voice symptoms of illness and, thus, at-risk for potential serious consequences caused by delay in diagnosis and treatment.

Entities:  

Mesh:

Year:  2004        PMID: 14983133     DOI: 10.1016/j.hrtlng.2003.08.003

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  4 in total

Review 1.  Short-term exposure to hypoxia for work and leisure activities in health and disease: which level of hypoxia is safe?

Authors:  Martin Burtscher; Klemens Mairer; Maria Wille; Hannes Gatterer; Gerhard Ruedl; Martin Faulhaber; Günther Sumann
Journal:  Sleep Breath       Date:  2011-04-16       Impact factor: 2.816

Review 2.  [Effects of acute altitude exposure: which altitude can be tolerated?].

Authors:  Martin Burtscher
Journal:  Wien Med Wochenschr       Date:  2010-07

Review 3.  High-altitude headache.

Authors:  Luiz P Queiroz; Alan M Rapoport
Journal:  Curr Pain Headache Rep       Date:  2007-08

4.  Factors associated with poor physical performance in older adults of 11 Peruvian high Andean communities.

Authors:  Diego Urrunaga-Pastor; Fernando M Runzer-Colmenares; Tania M Arones; Rosario Meza-Cordero; Silvana Taipe-Guizado; Jack M Guralnik; Jose F Parodi
Journal:  F1000Res       Date:  2019-01-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.